| Ganciclovir EP Impurity J | 177216-32-9 | C18H25N5O7 |
| Ganciclovir Imp. F (EP): 2-Amino-1,9-dihydro-6H-purin- 6-one (Guanine) | 73-40-5 | C5H5N5O |
| Ganciclovir Imp. H (EP): 2-Amino-7-[[2-hydroxy-1-(hydroxy- methyl)ethoxy]methyl]-1,7-dihydro-6H-purin-6- one (N-7 Isomer of Ganciclovir) | 84222-50-4 | C9H13N5O4 |
| Ganciclovir Imp. I (EP): 2-[(2-Amino-6-oxo-1,6-dihydro- 9H-purin-9-yl)methoxy]-propane-1,3-diyl Dipropanoate (Ganciclovir Dipropionate) | 86357-20-2 | C15H21N5O6 |
| Ganciclovir Imp. J (EP): 2-[2-(Propanoylamino)-6-oxo-1,6- dihydro-9H-purin-9-yl]methoxy]propane-1,3- diyl dipropanoate (Ganciclovir Tripropionate) | 177216-32-9 | C18H25N5O7 |
| Ganciclovir Impurity 1 | 1401562-16-0 | C15H25ClN6O5 |
| Ganciclovir Impurity 2 | 86357-14-4 | C15H19N5O7 |
| Ganciclovir Impurity 3 | 130914-77-1 | C35H43N7O10 |
| Ganciclovir Impurity 5 | 1202645-50-8 | C7H9N5O2 |
| Ganciclovir Impurity 10 | 86357-19-9 | C13H17N5O6 |
| Ganciclovir Impurity 13 | 298197-26-9 | C13H17N5O6 |
| Ganciclovir Impurity 14 | 130914-71-5 | C19H31N7O6 |
| Ganciclovir Impurity 16 | 1219792-42-3 | C14H22N6O5 |
| Ganciclovir Impurity 17 | 84245-12-5 | C11H15N5O5 |
| Ganciclovir Impurity D | 1346598-14-8 | C10H15N5O5 |
| Ganciclovir Mono-N-methyl Valinate Hydrochloride | Not available | C15H25ClN6O5 |
| Ganciclovir Mono-O-acetate | 88110-89-8 | C11H15N5O5 |
| Ganciclovir Mono-O-propionate | 194159-18-7 | C12H17N5O5 |
| Ganciclovir Related Compound A | 86357-09-7 | C9H13N5O4 |
| Ganciclovir Triacetate | 86357-14-4 | C15H19N5O7 |
| Garamine triacetate | Not available | C19H39N3O12 |
| Gatifloxacin Impurity 1 | 114213-69-3 | C20H24FN3O4 |
| Gefapixant | 1015787-98-0 | C14H19N5O4S |
| Gefapixant Impurity 1 | 865304-71-8 | C14H18N4O2 |
| Gefitinib Difluoro Impurity | 184475-50-1 | C22H24F2N4O3 |
| Gefitinib Dihydrochloride | 184475-56-7 | C22H26Cl3FN4O3 |
| Gefitinib EP Impurity B | 1603814-04-5 | C22H24ClFN4O3 |
| Gefitinib Hydrochloride | 184475-55-6 | C22H25Cl2FN4O3 |
| Gefitinib Hydrolysate Precursor (HCl) | 184475-70-5 | C17H14Cl2FN3O3 |
| Gefitinib Impurity 3 | 52805-46-6 | C8H7NO2 |
| Gefitinib Impurity 4 | 385784-68-9 | C12H15N3O2 |
| Gefitinib Impurity 5 | 675126-27-9 | C15H21N3O3 |
| Gefitinib Impurity 6 | 2089650-13-3 | C22H24Cl2N4O3 |
| Gefitinib Impurity 7 | 1608115-59-8 | C22H23ClFN3O4 |
| Gefitinib Impurity 8 | 214472-37-4 | C16H22N2O7 |
| Gefitinib Impurity 9 | 1640351-46-7 | C15H22N2O5 |
| Gefitinib Impurity 10 | 690206-97-4 | C16H13ClFN3O2 |
| Gefitinib Impurity 11 | 16064-25-8 | C8H6N2O2 |
| Gefitinib Impurity 12 | 385784-71-4 | C15H19N3O5 |
| Gefitinib Impurity 13 | 215659-03-3 | C9H9NO6 |
| Gefitinib Impurity 15 | 847949-50-2 | C22H25ClN4O4 |
| Gefitinib Impurity 19 | 1803045-02-4 | C22H24ClFN4O4 |
| Gefitinib Impurity 24 | 194423-17-1 | C10H12N4 |
| Gefitinib Impurity 25 | 214472-41-0 | C16H24N2O5 |
| Gefitinib Impurity 26 | 193552-54-4 | C18H16O6 |
| Gefitinib Impurity 28 | 1379208-77-1 | C8H6N2O4 |
| Gefitinib impurity 29 | 184475-35-2 | C22H24ClFN4O3 |
| Gefitinib Impurity 31 | 692059-41-9 | C12H12Cl2N2O2 |
| Gefitinib Impurity 32 | 72235-56-4 | C7H7ClFN |
| Gefitinib impurity 33 | Not available | C22H24ClFN4O3 |
| Gefitinib Impurity 35 | 861453-12-5 | C15H20N2O6 |
| Gefitinib Impurity 35 | 1325726-60-0 | C11H11BrN2O4 |
| Gefitinib Impurity 36 | 861453-11-4 | C15H21NO4 |
| Gefitinib Impurity 37 | 21397-08-0 | C6H5ClFN |
| Gefitinib Impurity 38 | 2106-04-9 | C6H5ClFN |
| Gefitinib Impurity 39 | 58749-47-6 | C8H7NO5 |
| Gefitinib Impurity 40 | 6702-50-7 | C9H10O4 |
| Gefitinib Impurity 43 | 3863-11-4 | C6H5F2N |
| Gefitinib Impurity 43 | 1072107-50-6 | C11H12ClNO5 |
| Gefitinib Impurity 44 | 675126-26-8 | C15H19N3O5 |
| Gefitinib Impurity 45 | 205584-69-6 | C9H6Cl2N2O |
| Gefitinib Impurity 47 | 1208903-74-5 | C8H8N2O2 |
| Gefitinib Impurity 48 | 385784-72-5 | C15H21N3O3 |
| Gefitinib Impurity 70 | 199327-59-8 | C16H20ClN3O3 |
| Gefitinib Impurity 72 | 179688-02-9 | C11H10N2O4 |
| Gefitinib Impurity 73 | 80547-65-5 | C8H7NO6 |
| Gefitinib impurity C | 847949-51-3 | C22H24ClFN4O4 |
| Gefitinib impurity F | 153437-78-6 | C16H13ClFN3O2 |
| Gefitinib Impurity G | 50413-44-0 | C9H11NO4 |
| Gefitinib impurity G | 847949-49-9 | C21H22ClFN4O3 |
| Gefitinib impurity H | 199327-61-2 | C16H21N3O4 |
| Gefitinib impurity I | 847949-56-8 | C20H22ClFN4O3 |
| Gefitinib Impurity K | 367-21-5 | C6H5ClFN |
| Gefitinib impurity K | 1006378-06-8 | C15H19N3O5 |
| Gefitinib impurity L | 246512-44-7 | C15H23N3O4 |
| Gefitinib impurity O | 861453-16-9 | C15H21N3O6 |
| Gefitinib Impurity P | 1502829-45-9 | C29H37ClFN5O4 |
| Gefitinib Impurity TE | 184475-68-1 | C22H25ClF2N4O3 |
| Gefitinib Intermediate I | 26759-46-6 | C10H13NO4 |
| Gefitinib Intermediate II | 13794-72-4 | C10H10N2O3 |
| Gefitinib Intermediate III | 179688-52-9 | C9H8N2O3 |
| Gefitinib Intermediate IV | 179688-53-0 | C11H10N2O4 |
| Gefitinib Intermediate V | 230955-75-6 | C11H9ClN2O3 |
| Gefitinib Intermediate VI | 788136-89-0 | C17H13ClFN3O3 |
| Gefitinib Intermediate VII | 184475-71-6 | C15H11ClFN3O2 |
| Gefitinib Intermediate VIII | 7357-67-7 | C7H14ClNO |
| Gefitinib N-Oxide | 847949-51-3 | C22H24ClFN4O4 |
| Gefitinib-13C-D3 | 1210608-91-5 | C22H24ClFN4O3 |
| Gefitinib-D3 | 1173976-40-3 | C22H24ClFN4O3 |
| Gefitinib-D6 | 1228664-49-0 | C22H24ClFN4O3 |
| Gefitinib-D8 | 857091-32-8 | C22H24ClFN4O3 |
| Gefitinib-PROTAC-3 | 2230821-27-7 | C47H57ClFN7O8S |
| Gemcitabine EP Impurity B | 122111-05-1 | C9H12ClF2N3O4 |
| Gemcitabine hydrochloride EP impurity A/Lamivudine EP impurity E | 71-30-7 | C4H5N3O |
| Gemcitabine Hydrochloride Imp. A (EP): 4-Aminopyrimidin-2(1H)-one (Cytosine) | 71-30-7 | C4H5N3O |
| Gemcitabine Hydrochloride Imp. C EP: 1-(2-Deoxy-2,2-difluoro- -D-erythro-pentofuranosyl) pyrimidin-2,4(1H,3H)-dione (2 -Deoxy-2 ,2 -difluorouridine) | 114248-23-6 | C9H10F2N2O5 |
| Gemcitabine Impurity 1 | 122111-01-7 | C19H14F2O6 |
| Gemcitabine Impurity 2 | 143157-22-6 | C19H16F2O6 |
| Gemcitabine Impurity 3 | 153381-14-7 | C9H10F2N2O5 |
| Gemcitabine Impurity 4 | 95058-77-8 | C5H6F2O4 |
| Gemcitabine Impurity 4 | 134877-42-2 | C20H18F2O8S |
| Gemcitabine Impurity 5 | 122111-12-0 | C5H6F2O4 |
| Gemcitabine Impurity 6 | 122111-02-8 | C19H14F2O6 |
| Gemcitabine Impurity 7 | 134790-39-9 | C23H19F2N3O6 |
| Gemcitabine Impurity 7 | 122111-07-3 | C12H10F2O5 |
| Gemcitabine Impurity 8 | 143234-91-7 | C14H16F2O6 |
| Gemcitabine Impurity 9 | 866473-31-6 | C19H16F2O7 |
| Gemcitabine Impurity 15 | 2174019-90-8 | C16H15F2N3O5 |
| Gemcitabine impurity A | 71-30-7 | C4H5N3O |
| Gemcitabine impurity C | 114248-23-6 | C9H10F2N2O5 |
| Gemcitabine impurity C | 114248-23-6 | C9H10F2N2O5 |
| Gemfibrozil EP impurity B | 114413-97-7 | C15H23NO2 |
| Gemfibrozil EP impurity C | Not available | C15H24O3 |
| Gemfibrozil EP impurity E | 500904-61-0 | C18H26O3 |
| Gemfibrozil EP impurity F | 500904-64-3 | C18H22O |
| Gemfibrozil EP impurity G | 3727-20-6 | C11H14O |
| Gemfibrozil EP impurity H | 415724-02-6 | C19H24O2 |
| Gemfibrozil EP impurity I | 149105-25-9 | C16H24O3 |
| Gemfibrozil Ethyl Ester | 63258-18-4 | C17H26O3 |
| Gemfibrozil for system suitability | 25812-30-0 | C15H22O3 |
| Gemfibrozil Imp. A (EP): 2,5-Dimethylphenol (p-Xylenol) | 95-87-4 | C8H10O |
| Gemfibrozil Imp. E (EP): 5-[2,5-Dimethyl-4-(prop-1-enyl)- phenoxy]-2,2-dimethylpentanoic Acid | 1315604-10-4 | C18H26O3 |
| Gemfibrozil Imp. H (EP): 1,3-Bis(2,5-dimethylphenoxy)- propane | 415724-02-6 | C19H24O2 |
| Gemfibrozil Imp. I (EP): Methyl 5-(2,5-dimethylphenoxy)-2,2- dimethylpentanoate (Gemfibrozil Methyl Ester) | 149105-25-9 | C16H24O3 |
| Gemfibrozil impurity 1 | 63258-18-4 | C17H26O3 |
| Gemfibrozil impurity 2 | 154021-24-6 | C18H28O3 |
| Gemfibrozil impurity 3 | 91683-38-4 | C21H30O9 |
| Gemfibrozil impurity E | 500904-61-0 | C18H26O3 |
| Gemfibrozil Impurity E | 500904-61-0 | C18H26O3 |
| Gemfibrozil Isobutyl Ester | Not available | C19H30O3 |
| Gemfibrozil Isobutyl Ester | 149105-26-0 | C19H30O3 |
| Gemfibrozil Isopropyl Ester | 154021-24-6 | C18H28O3 |
| Gemfibrozil methyl ester | 149105-25-9 | C16H24O3 |
| Gemfibrozil Related Compound A | 500904-61-0 | C18H26O3 |
| Gemigliptin | Not available | C18H19F8N5O2 |
| Geniposide methyl ester | 64421-28-9 | C17H26O11 |
| Genistein Diglucuronide | 428438-35-1 | C27H26O17 |
| Gentamicin B | 36889-15-3 | C19H38N4O10 |
| Gentamicin C1a | 26098-04-4 | C19H39N5O7 |
| Gentamicin C2 | 25876-11-3 | C20H41N5O7 |
| Gentamicin C2a | 59751-72-3 | C20H41N5O7 |
| Gentamicin C2b | 52093-21-7 | C20H41N5O7 |
| Gentamicin Sulfate C2 | 287916-51-2 | C20H41N5O7 |
| Gentamicin sulfate EP Impurity A | 32385-11-8 | C19H37N5O7 |
| Gentamicin sulfate EP Impurity B | 49751-51-1 | C13H27N3O6 |
| Gentamicin sulfate EP Impurity C | 36889-16-4 | C20H40N4O10 |
| Gentamicin sulfate EP Impurity D | Not available | C19H39N5O9 |
| Gentamicin Sulfate EP Impurity E | 2037-48-1 | C6H14N2O3 |
| Gentamicin Sulfate EP Impurity E DiHBr | 84107-26-6 | C6H16Br2N2O3 |
| Gentamicina | 1405-41-0 | C60H125N15O25S |
| Gentamicina | 1405-41-0 | C60H125N15O25S |
| Gentisic Acid | 490-79-9 | C7H6O4 |
| GENZ-123346 | 491833-30-8 | C24H38N2O4 |
| Geranylgeraniol-d5 | 174873-05-3 | C20H34O |
| Gestodene EP Impurity L | Not available | C21H26O2 |
| Gestodene for system suitability | 60282-87-3 | C21H26O2 |
| Gestodene Impurity 1 | 104933-97-3 | C21H28O4 |
| Gestodene impurity I | Not available | C22H30O3 |
| Gibberellin A19 | 6980-44-5 | C20H26O6 |
| Gibberellin A44 | 36434-15-8 | C20H26O5 |
| Gibberellin impurity 3 | 13744-18-8 | C20H26O4 |
| Gibberenone | 17924-92-4 | C18H22O5 |
| Gimeracil impurity 1 | 149143-68-0 | C6H3ClN2O2 |
| Gimeracil impurity 2 | 1379260-15-7 | C6H6ClNO2 |
| Gimeracil impurity 4 | 149143-67-9 | C6H5ClN2O3 |
| Gimeracil impurity 5 | 147619-40-7 | C7H5ClN2O2 |
| Gimeraux impurities1 | 52545-13-8 | C6H7NO2 |
| Gimeraux impurities2 | 21642-98-8 | C7H6N2O2 |
| Ginsenoside Rg1 reference substance | 22427-39-0 | C42H72O14 |
| Glabridin (racemate ) | 850582-15-9 | C20H20O4 |
| Glabridin (S configuration) | 872596-23-1 | C20H20O4 |
| Glibenclamide EP Impurity B | 21165-77-5 | C18H19ClN2O6S |
| Glibenclamide Imp. A (EP): 5-Chloro-2-methoxy-N-[2- (4-sulfamoylphenyl)ethyl]benzamide | 16673-34-0 | C16H17ClN2O4S |
| Glibenclamide Imp. B (EP): Methyl [[4-[2-[(5-Chloro-2- methoxybenzoyl)amino]ethyl]phenyl]- sulphonyl]carbamate | 21165-77-5 | C18H19ClN2O6S |
| Glibenclamide Imp. C (EP): 1-Cyclohexyl-3-[[4-[2-[(cyclohexylcarbamoyl) amino]ethyl]phenyl]sulfonyl]urea (N-(Cyclohexylcarbamoyl)-4- [2-[(cyclohexylcarbamoyl)amino]ethyl]benzenesulphonamide) | 10079-35-3 | C22H34N4O4S |
| Glibenclamide Imp. D (EP): 1-Butyl-3-[[4-[2-[(5-chloro-2-methoxybenzoyl) amino]ethyl]phenyl]sulfonyl]urea (1-[[4-[2-[(5-Chloro-2- methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-3-butylurea) | 38160-73-5 | C21H26ClN3O5S |
| Glibenclamide Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[(3,5-dichloro-2- methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]urea (1-[[4-[2-[(3,5- Dichloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]-3- cyclohexylurea) | 57334-89-1 | C26H40N2O5 |
| Glibenclamide impurity 1 | 2191-62-0 | C17H25N3O4S |
| Glibenclamide impurity 6 | 33924-49-1 | C16H16ClNO2 |
| Glibenclamide impurity 9 (5-Chloro-2-methoxybenzoic acid) | 3438-16-2 | C8H7ClO3 |
| Glibenclamide impurity 10 | 151890-69-6 | C19H21ClN2O6S |
| Glibenclamide impurity A | 16673-34-0 | C16H17ClN2O4S |
| Glibenclamide impurity B | 21165-77-5 | C18H19ClN2O6S |
| Glibenclamide impurity B | 21165-77-5 | C18H19ClN2O6S |
| Gliclazide EP Impurity B | 54786-86-6 | C7H12N2O |
| Gliclazide EP Impurity C | 5577-13-9 | C10H13NO4S |
| Gliclazide EP Impurity D | 1136426-19-1 | C15H20N2O3S |
| Gliclazide EP Impurity E | Not available | C15H19N3O3S |
| Gliclazide EP Impurity F | 1076198-18-9 | C15H21N3O3S |
| Gliclazide EP Impurity G | Not available | C15H19N3O3S |
| Gliclazide Imp. A (EP): 4-Methylbenzenesulphonamide | 70-55-3 | C7H9NO2S |
| Gliclazide Imp. B (EP): 2-Nitroso-octahydrocyclopenta- [c]pyrrole | 54786-86-6 | C7H12N2O |
| Gliclazide Imp. C (EP): Ethyl [(4-Methylphenyl)sulphonyl]- carbamate | 5577-13-9 | C10H13NO4S |
| Gliclazide Imp. F (EP): 1-(Hexahydrocyclopenta[c]pyrrol- 2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea | 1076198-18-9 | C15H21N3O3S |
| Gliclazide Impurity 1 | 38173-52-3 | C15H19N3O5S |
| Gliclazide Impurity 2 | 14437-03-7 | C9H11NO4S |
| Gliclazide Impurity 3 | 54528-00-6 | C7H14N2 |
| Gliclazide Impurity 3 HCl | 58108-05-7 | C7H15ClN2 |
| Gliclazide Impurity 5 | 39051-77-9 | C8H10N2O3S |
| Gliclazide Impurity 8 | 87368-00-1 | C15H21N3O4S |
| Gliclazide Impurity 9 | 1808087-53-7 | C15H19N3O3S |
| Gliclazide Impurity 10 | 32258-50-7 | C10H13NO4S |
| Gliclazide impurity B | 54786-86-6 | C7H12N2O |
| Gliclazide impurity F | Not available | C15H21N3O3S |
| Gliclazide Impurity F | 1076198-18-9 | C15H21N3O3S |
| Gliclazide impurity F | 1076198-18-9 | C15H21N3O3S |
| Glimepiride Carbamate | 119018-30-3 | C18H23N3O6S |
| Glimepiride cis-Isomer (Glimepiride Related Compound A) | 684286-46-2 | C24H34N4O5S |
| Glimepiride EP impurity A | 684286-46-2 | C24H34N4O5S |
| Glimepiride EP impurity B | 119018-29-0 | C16H21N3O4S |
| Glimepiride EP impurity C | 119018-30-3 | C18H23N3O6S |
| Glimepiride EP impurity D | 791104-62-6 | C24H34N4O5S |
| Glimepiride EP impurity F | Not available | C18H23N3O6S |
| Glimepiride EP impurity G | Not available | C19H25N3O6S |
| Glimepiride EP impurity H | Not available | C24H28N4O5S |
| Glimepiride for system suitability | 93479-97-1 | C24H34N4O5S |
| Glimepiride Imp. A (EP): 1-[[4-[2-[[(3-Ethyl-4-methyl-2- oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]- amino]ethyl]phenyl]sulphonyl]-3-(cis-4- methylcyclohexyl)urea (cis-Glimepiride) | 684286-46-2 | C24H34N4O5S |
| Glimepiride Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N-[2-(4- sulphamoylphenyl)ethyl]-2,3-dihydro-1H-pyrrole- 1-carboxamide (Glimepiride Sulphonamide) | 119018-29-0 | C16H21N3O4S |
| Glimepiride Imp. C (EP): Methyl [[4-[2-[[(3-Ethyl-4-methyl-2- oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]- ethyl]phenyl]sulphonyl]carbamate (Glimepiride Carbamate) | 119018-30-3 | C18H23N3O6S |
| Glimepiride Imp. D (EP): 1-[[3-[2-[[(3-Ethyl-4-methyl-2-oxo- 2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]- phenyl]sulphonyl]-3-(trans-4-methylcyclohexyl)- urea | 791104-62-6 | C24H34N4O5S |
| Glimepiride impurity 1 | 119043-16-2 | C16H19ClN2O4S |
| Glimepiride impurity 2 | 6850-63-1 | C8H17N |
| Glimepiride Impurity 7 | 32175-00-1 | C8H13NO |
| Glimepiride Impurity 12 | 878480-70-7 | C24H34N4O5S |
| Glimepiride Impurity 14 | 41176-98-1 | C16H25N3O3S |
| Glimepiride Impurity A | 2366968-77-4 | C16H21N3O4S |
| Glimepiride Related Compound A (glimepiride cis-isomer) | Not available | C24H34N4O5S |
| Glimepiride Related Compound B | 119018-29-0 | C16H21N3O4S |
| Glimepiride Related Compound B (glimepiride sulfonamide) | Not available | C16H21N3O4S |
| Glimepiride Related Compound C | 119018-30-3 | C18H23N3O6S |
| Glimepiride Related Compound D | 791104-62-6 | C24H34N4O5S |
| Glimepiride Sulfonamide | 119018-29-0 | C16H21N3O4S |
| Glipizide EP Impurity A (Trelagliptin EP Impurity A) | 33288-71-0 | C14H16N4O3S |
| Glipizide EP Impurity B | 157973-60-9 | C6H13N |
| Glipizide EP Impurity C (Trelagliptin EP Impurity C) | 13554-93-3 | C18H27N3O5S |
| Glipizide EP Impurity D (Trelagliptin EP Impurity D) | 1346600-54-1 | C14H16N4O3S |
| Glipizide EP Impurity E (Trelagliptin EP Impurity E) | 66375-96-0 | C21H27N5O4S |
| Glipizide EP Impurity F (Trelagliptin EP Impurity F) | 192118-08-4 | C11H16N2O4S |
| Glipizide EP Impurity G (Trelagliptin EP Impurity G) | 33288-74-3 | C16H18N4O5S |
| Glipizide EP Impurity H (Trelagliptin EP Impurity H) | 10080-05-4 | C15H23N3O3S |
| Glipizide EP Impurity I (Trelagliptin EP Impurity I) | 10079-35-3 | C22H34N4O4S |
| Glipizide EP Impurity J | 1076198-09-8 | C17H20N4O5S |
| Glipizide Imp. A (EP): 5-Methyl-N-[2-(4-sulphamoyl- phenyl)ethyl]pyrazine-2-carboxamide | 33288-71-0 | C14H16N4O3S |
| Glipizide Imp. B (EP): Cyclohexanamine | 108-91-8 | C6H13N |
| Glipizide Imp. E (EP): 1-Cyclohexyl-3-[[4-[2-[[(6-methyl- pyrazin-2-yl)carbonyl]amino]ethyl]phenyl]- sulphonyl]urea | 66375-96-0 | C21H27N5O4S |
| Glipizide Imp. F (EP): Ethyl [2-(4-Sulphamoylphenyl)- ethyl]carbamate | 192118-08-4 | C11H16N2O4S |
| Glipizide Imp. G (EP): Methyl [[4-[2-[[(5-Methylpyrazin- 2-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]- carbamate | 33288-74-3 | C16H18N4O5S |
| Glipizide Imp. H (EP): 4-[2-[(Cyclohexylcarbamoyl)amino]- ethyl]benzenesulphonamide | 10080-05-4 | C15H23N3O3S |
| Glipizide Imp. I (EP): N-(Cyclohexylcarbamoyl)-4-[2- [(cyclohexylcarbamoyl)amino]ethyl]benzene- sulphonamide | 10079-35-3 | C22H34N4O4S |
| Glipizide Impurity 4 (4-(2-Aminoethyl)benzenesulfonamide) | 35303-76-5 | C8H12N2O2S |